The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksD4T4.L Regulatory News (D4T4)

  • There is currently no data for D4T4

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares and TVR

15 Nov 2022 09:54

RNS Number : 4526G
D4T4 Solutions PLC
15 November 2022
 

 

D4t4 Solutions Plc

 

Transaction in Own Shares

and Total Voting Rights

 

D4t4 Solutions Plc (AIM: D4T4, the "Company") announces that on 14 November 2022 it purchased 17,964 ordinary shares of 2 pence each in the Company ("Ordinary Shares") at a price of 252.1 pence each, to be held in treasury.

Further to the above transaction, the Company advises that its issued share capital stands at 40,431,453 Ordinary Shares, with 495,226 Ordinary Shares held in treasury. Consequently, the total voting rights of the Company is 39,936,227.

The above voting rights figure of 39,936,227 may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Enquiries

D4t4 Solutions Plc

Bill Bruno, Chief Executive Officer

Ash Mehta, Chief Financial Officer

 

+44 (0) 1932 893333

investors@d4t4solutions.com

  

 

finnCap (Nominated Adviser & Joint Broker)

Julian Blunt / Edward Whiley, Corporate Finance

Alice Lane, ECM

 

+44 (0) 20 7220 0500

Canaccord Genuity (Joint Broker)

Simon Bridges / Andrew Potts

 

+44 (0) 20 7523 8000

 

About D4t4 Solutions Plc

D4t4 Solutions plc (AIM: D4t4) was founded around a passion for helping global enterprises derive value from their data assets.

Supporting customers in financial services, retail, travel, healthcare, and telecommunications across 27 countries, D4t4 enables businesses to make smarter, informed decisions via Celebrus, the Group's flagship first party data product suite. Celebrus CDP automatically captures, contextualises, and activates user-based behavioural data in real-time across all digital channels. Through behavioural biometrics and analytics, Celebrus FDP helps companies prevent fraud before it happens. Celebrus CDM provides an enterprise platform that automates the integration and transformation of customer data from all relevant data sources, whether on-premises or cloud, to deliver customer and regulatory analytics.

The Group has offices in the UK, USA, India, and Australia with key talent in all markets to drive the growth of the business. Celebrus is fully compliant with all major data privacy regulations and the Group is accredited to ISO27001: Information Security Management.

For more information, please see www.d4t4solutions.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUVVKRUAUAARA
Date   Source Headline
19th Apr 20217:00 amRNSBoard succession
19th Apr 20217:00 amRNSTrading update
1st Apr 202110:30 amRNSContract wins
26th Mar 20217:00 amRNSShare Buyback Programme
15th Mar 20217:00 amRNSTransaction in Own Shares and TVR
8th Mar 20217:00 amRNSTransaction in Own Shares and TVR
2nd Mar 20217:00 amRNSAppointment of Interim CFO
1st Mar 20215:11 pmRNSHolding(s) in Company
9th Feb 20217:00 amRNSDirectorate Change
27th Jan 20217:00 amRNSRelease of Celebrus Version 9.3
26th Jan 20219:15 amRNSDirector/PDMR holding, Exercise of Options & TVR
20th Jan 20217:00 amRNSExercise of Options and Total Voting Rights
11th Jan 20212:09 pmRNSHolding(s) in Company
8th Jan 20215:29 pmRNSDirectorate Change - Replacement
8th Jan 202111:33 amRNSDirectorate Change
2nd Dec 20207:00 amRNSNew contract wins
25th Nov 20207:00 amRNSHalf year results
18th Nov 20209:15 amRNSHolding(s) in Company
6th Nov 20209:00 amRNSNotice of Results
5th Nov 20209:05 amRNSSecond Price Monitoring Extn
5th Nov 20209:00 amRNSPrice Monitoring Extension
5th Nov 20207:00 amRNSNew contract wins
21st Oct 20209:05 amRNSSecond Price Monitoring Extn
21st Oct 20209:00 amRNSPrice Monitoring Extension
21st Oct 20207:00 amRNSTrading update, CMD and notice of results
13th Oct 202012:07 pmRNSHolding(s) in Company
24th Aug 20205:49 pmRNSTransaction in Own Shares and TVR
19th Aug 20207:00 amRNSOptions Exercise, Transaction in Own Shares & TVR
11th Aug 20205:13 pmRNSHolding(s) in Company
10th Aug 20201:31 pmRNSGrant of Awards under Long Term Incentive Plan
6th Aug 202010:26 amRNSResult of AGM
6th Aug 20207:00 amRNSAGM Statement
20th Jul 20207:00 amRNSTransaction in Own Shares & TVR
6th Jul 20209:33 amRNSTransaction in Own Shares and TVR
30th Jun 20207:00 amRNSAudited full year results
26th Jun 20207:00 amRNSHolding(s) in Company
12th Jun 20209:00 amRNSNotice of Results
9th Jun 20209:00 amRNSAppointment of Joint Broker
4th Jun 20208:19 amRNSHolding(s) in Company
15th May 20207:00 amRNSLaunch of Celebrus machine learning solution
5th May 202012:29 pmRNSDirectorate appointment
8th Apr 20207:00 amRNSTrading Statement
31st Mar 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Mar 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Mar 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Mar 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Mar 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Mar 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
17th Mar 20203:32 pmRNSHolding(s) in Company
17th Mar 20207:00 amRNSShare Buy Back

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.